Renagel (R): reducing serum phosphorus in haemodialysis patients

Authors
Burke, SK
Citation
Sk. Burke, Renagel (R): reducing serum phosphorus in haemodialysis patients, HOSP MED, 61(9), 2000, pp. 622-627
Citations number
24
Categorie Soggetti
General & Internal Medicine
Journal title
HOSPITAL MEDICINE
ISSN journal
14623935 → ACNP
Volume
61
Issue
9
Year of publication
2000
Pages
622 - 627
Database
ISI
SICI code
1462-3935(200009)61:9<622:R(RSPI>2.0.ZU;2-J
Abstract
Approximately half of all dialysis patients experience persistent hyperphos phataemia, which causes significant problems. Renagel(R) is a calcium-free, aluminium-free phosphate binder which reduces serum phosphorus in haemodia lysis patients by reducing absorption of dietary phosphorus. This article r eviews the management of hyperphosphataemia and presents some Renagel(R) cl inical trial data.